Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases

Summary

This phase I trial studies the side effects and best dose of hydroxychloroquine in treating patients with solid tumors undergoing radiation therapy for bone metastases. Drugs, such as hydroxychloroquine, may make tumor cells more sensitive to radiation therapy

Timeline

Start

2011-08

Primary completion

2014-07

Completion

2014-07

Outcome

Outcome not reported

Stopped: “Recently published data that has shown HCQ to be safe when combined with chemo and or radiation at even higher doses than what is used in this study.”

Drugs

Indications